FDA releases guidance on labeling of drug use-related software outputs
Regulatory NewsJeff Craven
Biologics/ biosimilars/ vaccinesCombination products/companion diagnosticsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/PolicyRegulatory NewsJeff CravenBiologics/ biosimilars/ vaccinesCombination products/companion diagnosticsMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy